Pharmadrug (TSE:PHRX)
CNQX:PHRX

Pharmadrug (PHRX) Financial Statements

29 Followers

Pharmadrug Financial Overview

Pharmadrug's market cap is currently ―. The company's EPS TTM is C$-0.261; its P/E ratio is -0.06; Pharmadrug is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---C$ -105.21KC$ 2.53K
Gross Profit---C$ -24.44KC$ 2.53K
EBITC$ -279.00KC$ -346.24KC$ -107.41KC$ 2.89MC$ -2.96M
EBITDAC$ -273.11KC$ -330.00KC$ -91.35KC$ 2.59MC$ -2.95M
Net Income Common StockholdersC$ -300.01KC$ -419.98KC$ -178.77KC$ -582.18KC$ -852.33K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 188.42KC$ 118.55KC$ 220.62KC$ 329.24KC$ 688.19K
Total AssetsC$ 11.94MC$ 11.88MC$ 11.99MC$ 12.11MC$ 12.60M
Total DebtC$ 1.60MC$ 1.58MC$ 1.39MC$ 1.42MC$ 1.40M
Net DebtC$ 1.41MC$ 1.46MC$ 1.17MC$ 1.09MC$ 710.47K
Total LiabilitiesC$ 3.70MC$ 3.64MC$ 3.33MC$ 3.28MC$ 3.20M
Stockholders EquityC$ 7.94MC$ 8.24MC$ 8.66MC$ 8.84MC$ 9.40M
Cash Flow-
Free Cash FlowC$ -200.86KC$ -130.02KC$ -92.26KC$ -61.98KC$ -322.17K
Operating Cash FlowC$ -200.86KC$ -130.02KC$ -92.26KC$ -63.56KC$ -322.17K
Investing Cash FlowC$ 8.04KC$ 37.84KC$ 207.92KC$ 78.44KC$ 3.47K
Financing Cash Flow-C$ 93.15KC$ -116.54KC$ -68.45KC$ 567.30K
Currency in CAD

Pharmadrug Earnings and Revenue History

Pharmadrug Debt to Assets

Pharmadrug Cash Flow

Pharmadrug Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis